J Řehák

863 total citations
48 papers, 630 citations indexed

About

J Řehák is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, J Řehák has authored 48 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Ophthalmology, 19 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in J Řehák's work include Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (20 papers) and Glaucoma and retinal disorders (16 papers). J Řehák is often cited by papers focused on Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (20 papers) and Glaucoma and retinal disorders (16 papers). J Řehák collaborates with scholars based in Czechia and Germany. J Řehák's co-authors include Matúš Rehák, Martin Šín, Kateřina Langová, Luděk Slavík, Peter Wiedemann, Ladislav Dušek, A. Siegemund, Markus Scholz, Dirk Hasenclever and Frank Faude and has published in prestigious journals such as American Journal of Ophthalmology, Thrombosis and Haemostasis and Graefe s Archive for Clinical and Experimental Ophthalmology.

In The Last Decade

J Řehák

42 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Řehák Czechia 12 531 298 71 67 47 48 630
J. Michael Lahey United States 13 540 1.0× 396 1.3× 52 0.7× 125 1.9× 46 1.0× 16 631
Gülcan Kural Türkiye 15 409 0.8× 132 0.4× 36 0.5× 44 0.7× 25 0.5× 45 532
Niral Karia United Kingdom 9 468 0.9× 365 1.2× 13 0.2× 85 1.3× 85 1.8× 14 509
Michaela Goldstein Israel 11 373 0.7× 270 0.9× 15 0.2× 28 0.4× 30 0.6× 18 417
Uday R. Desai United States 15 535 1.0× 399 1.3× 14 0.2× 128 1.9× 19 0.4× 40 637
S. Rodman Irvine United Kingdom 8 406 0.8× 163 0.5× 34 0.5× 52 0.8× 22 0.5× 17 593
W E Schulenburg United Kingdom 11 192 0.4× 328 1.1× 23 0.3× 14 0.2× 38 0.8× 16 445
Sandeep Randhawa United States 10 208 0.4× 78 0.3× 11 0.2× 89 1.3× 18 0.4× 54 330
Timothy D. Matthews United Kingdom 6 180 0.3× 39 0.1× 19 0.3× 204 3.0× 24 0.5× 10 332
A J Brucker United States 11 518 1.0× 404 1.4× 13 0.2× 47 0.7× 30 0.6× 13 591

Countries citing papers authored by J Řehák

Since Specialization
Citations

This map shows the geographic impact of J Řehák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Řehák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Řehák more than expected).

Fields of papers citing papers by J Řehák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Řehák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Řehák. The network helps show where J Řehák may publish in the future.

Co-authorship network of co-authors of J Řehák

This figure shows the co-authorship network connecting the top 25 collaborators of J Řehák. A scholar is included among the top collaborators of J Řehák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Řehák. J Řehák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Řehák, J, et al.. (2018). Correlation Between Ischemic Index of Retinal Vein Occlusion and Oxygen Saturation in Retinal Vessels. American Journal of Ophthalmology. 188. 74–80. 17 indexed citations
4.
Jarkovský, Jiří, Jan Studnička, Martin Šín, et al.. (2015). The efficacy of ranibizumab treatment in clinical practice in patients with the wet form of age-related macular degeneration. The results of the Czech National Registry. Biomedical Papers. 159(3). 407–412. 2 indexed citations
5.
Fryšák, Zdeněk, et al.. (2014). Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomedical Papers. 159(2). 307–312. 12 indexed citations
6.
Hollborn, Margrit, J Řehák, Ianors Iandiev, et al.. (2013). Effects of arteriolar constriction on retinal gene expression and Müller cell responses in a rat model of branch retinal vein occlusion. Graefe s Archive for Clinical and Experimental Ophthalmology. 252(2). 257–265. 14 indexed citations
7.
Studnička, Jan, E Rencová, P Rozsíval, et al.. (2013). Cost and Effectiveness of Therapy for Wet Age-Related Macular Degeneration in Routine Clinical Practice. Ophthalmologica. 230(1). 34–42. 8 indexed citations
8.
Šín, Martin, et al.. (2012). Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD. Biomedical Papers. 158(1). 138–143. 3 indexed citations
9.
Studnička, Jan, E Rencová, P Rozsíval, et al.. (2012). Effects of treatment change in patients with neovascular age-related macular degeneration; Results from the Czech National Registry. Biomedical Papers. 156(4). 359–364. 1 indexed citations
10.
Večeřová, Renata, et al.. (2011). The in vitro antimicrobial activity of silicone oils used in ophthalmic surgery. Biomedical Papers. 156(1). 7–13. 11 indexed citations
11.
Řehák, J, et al.. (2010). The contact and immersion ultrasound methods compared using the ray tracing method. Optica Applicata. 40. 5 indexed citations
12.
Rehák, Matúš, et al.. (2010). The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Canadian Journal of Ophthalmology. 45(2). 171–175. 38 indexed citations
13.
Řehák, J, et al.. (2010). Initial Visual Acuity Is an Important Prognostic Factor in Patients with Branch Retinal Vein Occlusion. Ophthalmic Research. 45(4). 204–209. 20 indexed citations
14.
Řehák, J, et al.. (2009). A theoretical model of the human eye based on ultrasound and corneal data. Optica Applicata. 39. 1 indexed citations
15.
Řehák, J & Matúš Rehák. (2008). Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities. Current Eye Research. 33(2). 111–131. 320 indexed citations
16.
Rehák, Matúš, J Řehák, Frank Faude, et al.. (2008). The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Thrombosis and Haemostasis. 99(11). 925–929. 54 indexed citations
17.
Rehák, Matúš, et al.. (2008). [Disturbances of the plasma coagulation defects in retinal venous occlusions].. PubMed. 64(3). 108–11. 1 indexed citations
18.
Řehák, J. (1993). [Retinal vein occlusion. III. Arteriolar constriction].. PubMed. 49(3). 151–4. 1 indexed citations
19.
Řehák, J. (1992). Neovascular glaucoma and intraocular pressure: I. Pathogenesis of increased intraocular pressure and therapy (a review of historical and current therapeutic modalities).. PubMed. 133. 71–3. 1 indexed citations
20.
Řehák, J. (1992). Painful eye in neovascular glaucoma and its treatment with cryocoagulation.. PubMed. 134. 109–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026